Intelligence · Clinical Pipeline
Gilead Sciences Ireland Pipeline
All ClinicalTrials.gov programs at Gilead Sciences Ireland — phase, modality, and trial IDs.
- Programs
- 6
Quick answer
Gilead Sciences Ireland has 6 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
B/F/TAF
Gilead Sciences Ireland UC
HIV-1-infection
1 trial -
Evixapodlin
Gilead Sciences Ireland UC
Advanced Solid Tumors
1 trial -
GS-0272
Gilead Sciences Ireland UC
Rheumatoid Arthritis
1 trial -
GS-2829
Gilead Sciences Ireland UC
Chronic Hepatitis B
1 trial -
Lanraplenib.
Gilead Sciences Ireland UC
Inflammatory Disease
1 trial -
SOF/VEL/VOX
Gilead Sciences Ireland UC
HCV Infection
1 trial
Frequently asked questions
How many pipeline programs does Gilead Sciences Ireland have?
6 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs